Background: Guggul, the gum resin obtained from Commiphora mukul, is one of the components of various formulations of traditional Ayurvedic medicine to treat inflammation, atherosclerosis, and weight loss. This research work describes Guggul lipid as a carrier and synergistic effect for anti-inflammatory drugs.
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The topical drug delivery system offers major obstacle of low diffusion rate of drug across the skin. Several strategies were proposed to increase permeation of drugs across the membrane.
One of the most promising strategies is vesicle based permeation [16] . Vesicles in topical drug delivery can be used as permeation enhancer, deliver entrapped drug through skin and act as rate limiting membrane barrier and modulate systemic absorption.
Guggul is a natural gum resin which is obtained from plant Commiphora Mukul or Commiphora Wightii belonging to family Burceacea. This oleo gum resin is generally used in Ayurvedic formulations for treatment of obesity, inflammation, rheumatism, acne, arthrosclerosis etc. The purpose of using guggul is to produce synergistic effect and to provide medicinal value to Guggulosomes. Guggul produces bioactive compounds such as guggulsterone (E and Z stereoisomer) and guggul lipid. A new triterpene Myrrhanol A is isolated from Commiphora Mukul which produces potent anti-inflammatory effect by reducing regulation of inflammatory mediators such as interleukins, transcription factor, and collagenase and hyaluronidase enzymes [5] . Guggulsterones also supports in platelet functioning and fibrinolytic activity and also in maintain cardiovascular support [6] [7] . Phenylbutazone is an acidic, lipophilic, NSAID, categorized under anti-inflammatory category has been recommended for arthritis, pain, inflammation property. It bounds highly to plasma protein. Phenylbutazone exerts its antiinflammatory action by inhibiting the Cyclooxygenase enzyme and by inhibiting inflammatory mediators such as PGs. Using guggulosomes topically can eliminate side effects, increase patient compliance and avoid first pass metabolism. In guggulosomes, phenylbutazone was used as drug which has anti-inflammatory property which resembles with property of guggul lipid and causes synergistic effect also helps in reducing drug dose in formulations and helps in minimizing side effect.

Purification of guggul
Guggul was extracted from Commiphora Mukul by hot water immersion technique. Guggul purification provides with two objectives first to increase its medicinal value and next to remove impurities. Purification is done in 2 steps. Firstly external impurities are removed manually such as dry leaves and other foreign material. Secondly by keeping guggul in muslin cloth bag was hanged in beaker so that it is immersed in hot water for overnight. Quantity of water should be more than guggul. Next morning, content of muslin cloth is thrown; water is heated gently at low temperature to prevent loss of volatile oils and other constituents (50 -60•C). Mixture is stirred continuously. When water is heated till half quantity it is filtered (generally when hot as it solidifies on cooling) and soft mass is dried in sun. After pure guggul is obtained it is triturated with small amount of ghee or butter [8].
Preparation of Guggulosomes by trituration method
Guggulosomes were prepared by using different ratios of purified guggul lipid and cholesterol with ethanol and water. Guggul lipid was weighed accurately and dissolved in 10 milliliters of distilled water with continuous stirring on magnetic stirrer at 700 rpm till guggul was completely dissolved in distilled water, phenylbutazone and cholesterol was dissolved in ethanol till a thin layer is formed. Both mixtures were mixed and adjusted volume up to 20 milliliters by 5% PVA solution. Mixture was triturated continuously to result in fine vesicles.
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Characterization of guggulosomes
Attenuated total reflection-Fourier transform infrared spectroscopy (FTIR)
Infrared spectra of guggulosomes loaded with phenylbutazone, guggul (GL), cholesterol (CH), and polyvinyl alcohol formulation were analyzed by using a ATR-FTIR spectra at room temperature by Bruker EQUINOX 55 FTIR spectrophotometer equipped with a liquid nitrogen cooled mercury cadmium telluride (MCT) detector at a nominal resolution of 2 cm -1 . The internal reflection element (IRE) was a diamond, with an incidence angle of 45°, scans 32, 21
resolutions leading to one internal reflection. An advanced ATR correction was applied to all spectra, and the region from 4000 to 400 cm-1 was peak fit using Opus software.
Scanning electronic microscopy (SEM)
Surface morphology was conducted by scanning electronic microscopy SEM (CSIR-CEERI, Kota, Rajasthan) by using lyophilized sample was mounted onto double sided carbon tape secured on copper stubs and coated with platinum operated at 20 kV and then analyzed at different magnification of 3300X.
Atomic force microscopy (AFM)
In this study, Atomic Force Microscope (AFM) was carried out on AIST-NT (model no. Smart SPM 1000). The images of the optimized guggulosomes were captured in AC mode and imaging tip is used for the guggulosomes is AIST FP Tip no. 01. The software used for the capturing of the images is AIST-NT SPM Control software and Mica slips were used to prepare the AFM slides for guggulosomal suspension. Approx. 10 µl guggulosomal suspension was dropped onto the mica slip and then a thin coating was formed using spin coater dryer machine.
Thickness of slide adjusted manually by dropping more or less suspension consequently. The prepared slide was kept under the lens and analyzed at different magnifications and three dimensional structures were observed. 
Differential scanning calorimeter (DSC)
M
Thermo gravimetric analysis (TGA)
TGA studies of phenylbutazone(PBZ), guggul (GL), cholesterol (CH) ,polyvinyl alcohol (PVA)and lyophilized formulations was done in order to study physical and chemical properties with the help of PROTEUS Thermal analysis (TGA 400). TGA is also used to determine weight loss, vaporization, sublimation, absorption, adsorption, etc. TGA is generally used to conclude selected characteristics of samples that show either weight loss or gain due to decomposition.
The small amount of samples was taken in a crucible and after tarring the weight of crucible was kept in assembly and software was made to run. The amount of weight loss graphs were obtained and reported [21] .
Entrapment efficiency
Amount of drug entrapped is calculated by deducting amount of un-entrapped drug by amount of total drug added initially. Entrapment capacity of phenylbutazone loaded guggulosomal suspension was determined by ultracentrifuge (Remi) equipped with TLA-45 rotor at 10,000rpm at 4 C for 1hr. After separation of phenylbutazone entrapped guggulosomes vesicles, amount of un-entrapped determined by using UV/Vis-spectrophotometry at 213nm. Each sample was analyzed in triplicate [22] [23] . The amount of drug entrapped in vesicles was calculated by equation given below:
Particle size analysis and Zeta potential
The guggulosomal vesicle size and zeta potential of optimized guggulosomes suspension was determined by dynamic light scattering (DLS) using a Malvern Zeta master UK. Guggulosomes were dispersed in Millipore water and system was set at an angle of 90° at 25°C, a medium with viscosity of 0.8872 and refractive index of 1.330. The particle size distribution was characterized using PDI, which determine the width of size distribution. Zeta potential was determined by using Malvern Zetasizer Nano ZS (Malvern Instruments, UK) performed by using a combination of laser Doppler velocimetry and phase analysis light scattering (PALS) [13, 18] . All measurements were taken as triplicate [13] [14] .
Viscosity
In this study, Brookfield DV III ultra V6.0 RV cone and plate rheometer (Brookfield Engineering Laboratories, Inc., Middleboro, MA, USA) was used to determine the viscosity of Guggulosomal gel using spindle number CPE40 at 25 ± 0.5 ∘C [34]. All measurements were taken as triplicate for an accurate result.
In vitro drug release
The in vitro drug release study of phenylbutazone guggulosomal gel was studied on cellulose acetate membrane which was soaked for 24hr prior work so that it can easily tie to diffusion tube. Diffusion tube was clamped and dipped in phosphate buffer 7.4 in beaker. It was kept at 37•C of phosphate buffer 7.4 and 1gm of phenylbutazone guggulosomal gel was added in donor compartment of the diffusion tube followed by parafilm covering to avoid evaporation of the solvent system. The phosphate buffer 7.4 was kept in receiver compartment and stirred continuously at 500 rpm. From receptor compartment 3ml solution was withdrawn at 0,1,2……8,….24, & 25 hours respectively at particular time interval and replaced by buffer solution so that volume of receptor solution kept constant during drug release [2, 8] . The drug concentrations in the withdrawn samples were determined at 213 nm against appropriate blank.
The in-vitro drug release were carried out in triplicate for each preparation and expressed as the Mean ± SD., and further the cumulative drug release (%CDR) was calculated and a plot of time M A N U S C R I P T
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versus %CDR was constructed and shown graphically. In vitro skin permeation studies were conducted for all guggulosomes formulation and reported [23] [24] .
Anti-inflammatory activity
In this study, the Carrageenan induced paw edema method was used to perform the Antiinflammatory activity of guggulosomes. In this study, six healthy rats were taken of weight 140-150 gm of either sex and they were further divided into two groups one for control and another for treatment (guggulosomes, 100mg/Kg). These two groups of rats were fasted overnight prior Where, Vt = mean paw volume edema inhibition by treatment (guggulosomes) Vo = mean paw volume edema inhibition by control (standard drug)
Stability studies
Stability studies were performed for guggulosomes suspension to investigate any loss of drug from guggulosomes and effect of stability during storage condition. From the study, optimized formulation F3 guggulosomes formulation was subjected to accelerated stability studies as per ICH guidelines [33] . Than the guggulosomes suspensions was stored in the glass vials at room temperature (25 ºC) and 4ºC to 3 months. Further the stability study was performed with the function of time (in days) as 7, 15, 30, 60, and 90 days according to the ICH guidelines. Then the guggulosomal suspension was withdrawn according to the given protocol and stability was justified by particle size, zeta potential, PDI, entrapment efficiency and thermal analysis. PDI and encapsulation efficiency [24] .
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Response surface methodology
In this present study, Response surface methodology (RSM) is used to describe the influence of guggul lipid and cholesterol on the formulations. RSM is a statistical technique that is basically used for the optimization of best experimental result with respect to their variables [28] . RSM explores the relationships between several independent variables (factors) and one or more dependent variables (responses) [29] . This experiment design is flexible and do not require any experts, it generates result itself and rejects if the data not fits to the selected model. If the experimental data fits to the proposed model then the software construct a polynomial equation that describes characteristics of the designed experiment.
In this experiment, Six Guggulosome formulations were prepared and the effect of independent variables on responses (dependent factors) were evaluated using RSM [30] [31] and are presented in (Fig. 8) Table 3 . Statistica V.10_ software (StatSoft, Inc. USA) was used for generation and evaluation of response surfaces.
Result and discussion
The ATR-FTIR results of pure drug, guggul lipid, cholesterol and phenylbutazone loaded guggulosomes containing major absorption band peaks are shown in (Fig.1) In this analysis, the optimized formulation A) F3, B) Guggul lipid, C) Phenylbutazone and D)
Cholesterol were subjected to controlled temperature program in a controlled atmosphere. The combined TGA graph shown in (Fig.4) , that the TGA graph of pure drug showed that the mass M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
remained constant with increasing temperature but as it approached melting point of drug, the started to fallen down. Similar phenomenon was also observed with the formulated guggulosome F3 which shown a sharp falling of the curve at the 250 C, that reveals that the combination of guggul lipid with the drug enhances its stability. An another TGA study was done for the guggul alone and its shown a sharp falling curve at 140 C. all these findings revealed that excipients or moisture content have no adverse effect on formulations.
The entrapment efficiency of drug in guggulosomes is dependent on numerous factors like the (Table 2 ). we can say that the an appropriate ratio of guggul and cholesterol conc. play an important role in the entrapment efficiency, this is due to increase in overall lipid conc. that favors the nature of drug to be encapsulate in the core as a whole.
The particle size and polydispersity index (PDI) were determined by using dynamic light scattering technique and are show in Table 2 . All the formulations, F1-F6 showed mean particle diameter sizes ranging from 230.2±0.14 to 342.3±3.04 nm with PDI ranging between 0.225±0.32 to 0.614±0.27. Formulation F3 containing guggul lipid (400mg) and cholesterol (400mg) with the same amount of drug (150mg) has shown the mean particle size (287.3± 1.13), which is an optimum formulation having PDI (0.289±0.23). By the help of above observations we can conclude that particle size of F3 shown in (Fig. 5 ) was suitable for topical use.
The guggulosomal formulations F1 to F6 showed zeta potential value ranging from -20.1to -35.7mV are shown in (Table 2. 
Conclusion
Guggulosomes were prepared by trituration method by using different ratios of lipids to enhance topical delivery. From all above results revealed that formulation F3 of ratio All data expressed as mean ± S.D.; ݊ = 3; ܲ ≤ 0.05. M A N U S C R I P T 
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